| Ciaran M Mannion, MD | |
|
30 Prospect Ave, Hackensack, NJ 07601-1914 | |
| (201) 996-2000 | |
| Not Available |
| Full Name | Ciaran M Mannion |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 34 Years |
| Location | 30 Prospect Ave, Hackensack, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659309284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 25MA07108000 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Jfk Medical Center | Edison, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hackensack Pathology Associates, Llc | 2365589298 | 16 |
News Archive
The single largest research project ever to be undertaken by the European Society of Cardiology (ESC), EUROACTION, showed that a multidisciplinary, family based and nurse coordinated programme made a real difference in improving lifestyle and reducing cardiovascular risk among coronary patients and people with a high risk of developing Cardiovascular Disease (CVD).
A team of cardiovascular researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University of California, San Diego have identified a small, but powerful, new player in the onset and progression of heart failure.
Application Security, Inc., the leading provider of database security, risk and compliance (SRC) solutions for the enterprise, today announced the formation of the Data Security Alliance™ (DSA) to enable organizations to strengthen their database security posture with an industry-leading, extensible and data-centric approach to protecting sensitive data.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
A Kansas State University-led study has discovered the role of a protein in bacteria that cause a wide variety of diseases, including typhoid fever, plague, meningitis and dysentery. The results may lead to new and improved antibiotics for humans and animals.
› Verified 8 days ago
| Entity Name | Hackensack Pathology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184856031 PECOS PAC ID: 2365589298 Enrollment ID: O20091027000288 |
News Archive
The single largest research project ever to be undertaken by the European Society of Cardiology (ESC), EUROACTION, showed that a multidisciplinary, family based and nurse coordinated programme made a real difference in improving lifestyle and reducing cardiovascular risk among coronary patients and people with a high risk of developing Cardiovascular Disease (CVD).
A team of cardiovascular researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University of California, San Diego have identified a small, but powerful, new player in the onset and progression of heart failure.
Application Security, Inc., the leading provider of database security, risk and compliance (SRC) solutions for the enterprise, today announced the formation of the Data Security Alliance™ (DSA) to enable organizations to strengthen their database security posture with an industry-leading, extensible and data-centric approach to protecting sensitive data.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
A Kansas State University-led study has discovered the role of a protein in bacteria that cause a wide variety of diseases, including typhoid fever, plague, meningitis and dysentery. The results may lead to new and improved antibiotics for humans and animals.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ciaran M Mannion, MD Po Box 23650, Newark, NJ 07189-0001 Ph: (800) 832-8244 | Ciaran M Mannion, MD 30 Prospect Ave, Hackensack, NJ 07601-1914 Ph: (201) 996-2000 |
News Archive
The single largest research project ever to be undertaken by the European Society of Cardiology (ESC), EUROACTION, showed that a multidisciplinary, family based and nurse coordinated programme made a real difference in improving lifestyle and reducing cardiovascular risk among coronary patients and people with a high risk of developing Cardiovascular Disease (CVD).
A team of cardiovascular researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University of California, San Diego have identified a small, but powerful, new player in the onset and progression of heart failure.
Application Security, Inc., the leading provider of database security, risk and compliance (SRC) solutions for the enterprise, today announced the formation of the Data Security Alliance™ (DSA) to enable organizations to strengthen their database security posture with an industry-leading, extensible and data-centric approach to protecting sensitive data.
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
A Kansas State University-led study has discovered the role of a protein in bacteria that cause a wide variety of diseases, including typhoid fever, plague, meningitis and dysentery. The results may lead to new and improved antibiotics for humans and animals.
› Verified 8 days ago
Min W Han, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 201-996-2000 | |
Dr. Maher Albitar, Pathology Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-5806 | |
Carol J Fehmian, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 201-996-2000 | |
Pritish Bhattacharyya, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 201-996-2000 | |
Aaron Sohn, MD Pathology Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave., Hackensack, NJ 07601 Phone: 551-996-2000 | |
Michael J Goldfischer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 201-996-2000 | |
Xiao Yan Yang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 201-996-2000 |